Lv11
20 积分 2026-03-18 加入
Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
7小时前
待确认
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis
9小时前
已完结
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
3个月前
已完结
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
3个月前
已完结
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer
3个月前
已完结
Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial
3个月前
已完结
Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer
3个月前
已完结
LBA98 Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial
4个月前
已完结
The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer
4个月前
已完结
Clinicopathological and molecular characteristics and treatment outcomes of SMARCA4-deficient thoracic tumors: a comprehensive analysis
4个月前
已完结
皖公网安备34019202002308
